#1 Clinical Trials Search in Europe

Phenobarbital

Phenobarbital is a medication that has been studied extensively in clinical trials for various conditions, particularly seizures in newborns and children. This article summarizes key findings from recent clinical trials investigating the use of phenobarbital for neonatal seizures, alcohol withdrawal, and other neurological disorders. We’ll explore its efficacy, safety, and potential benefits compared to other treatments.

Table of Contents

What is Phenobarbital?

Phenobarbital is a medication that belongs to a class of drugs called barbiturates. It is also known by other names such as phenobarbitone, solfoton, and luminal[1]. This drug has been used for many years to treat various conditions, primarily those affecting the brain and nervous system.

Uses of Phenobarbital

Phenobarbital is used to treat several medical conditions, including:

  • Neonatal Seizures: It is commonly used as a first-line therapy for seizures in newborn babies[2].
  • Epilepsy: It can be used to treat various types of seizures in both children and adults[3].
  • Status Epilepticus: This is a severe, prolonged seizure condition that phenobarbital can help manage[4].
  • Alcohol Withdrawal: In some cases, phenobarbital is used to manage symptoms of alcohol withdrawal[5].
  • Neonatal Abstinence Syndrome: This condition occurs in newborns exposed to certain drugs during pregnancy, and phenobarbital can help manage the symptoms[1].

How Phenobarbital Works

Phenobarbital works by enhancing the effects of a neurotransmitter called GABA (gamma-aminobutyric acid) in the brain. GABA is a chemical that helps to calm brain activity. By increasing GABA’s effects, phenobarbital can help reduce excessive electrical activity in the brain, which is what causes seizures[2].

Administration and Dosage

The administration and dosage of phenobarbital can vary depending on the condition being treated and the patient’s age. Here are some common methods:

  • Intravenous (IV) Injection: For quick action, especially in emergency situations like status epilepticus, phenobarbital can be given through an IV[4].
  • Oral Medication: For long-term treatment, phenobarbital is often given as a pill or liquid to be taken by mouth[6].
  • Dosage for Newborns: In treating neonatal seizures, a common starting dose is 20 mg/kg, which may be increased if needed[2].

It’s crucial to follow your doctor’s instructions precisely when taking phenobarbital. Never adjust the dose without consulting your healthcare provider.

Research and Clinical Trials

Phenobarbital has been the subject of numerous clinical trials to better understand its effectiveness and safety. Some notable research includes:

  • Studies comparing different doses of phenobarbital for neonatal seizures[2].
  • Research on the use of phenobarbital versus other medications for alcohol withdrawal[5].
  • Trials examining the long-term effects of phenobarbital use in infants[6].
  • Studies on the genetic factors that may influence how individuals respond to phenobarbital[7].

Side Effects and Precautions

Like all medications, phenobarbital can cause side effects. Some potential side effects include:

  • Drowsiness or sedation
  • Dizziness
  • Nausea
  • Confusion
  • Respiratory depression (slowed breathing)

In newborns, there are concerns about the potential long-term effects of phenobarbital on brain development. Some studies are investigating whether prolonged use might affect cognitive outcomes[6].

It’s important to discuss any concerns about side effects with your healthcare provider. They can help weigh the benefits of the medication against potential risks for your specific situation.

Aspect Details
Primary Use Treatment of neonatal seizures and status epilepticus
Dosage Studied 20 mg/kg and 40 mg/kg loading doses for neonatal seizures
Comparison Treatments Lorazepam, midazolam, clonidine (for various conditions)
Other Conditions Studied Alcohol withdrawal syndrome, prevention of intracranial hemorrhage in premature infants
Safety Considerations Potential effects on long-term brain development, need for careful monitoring
Genetic Factors CYP2C9 and CYP2C19 polymorphisms may affect phenobarbital metabolism
Ongoing Research Optimal dosing strategies, long-term outcomes, use in combination with other treatments

FAQ

  • What is phenobarbital primarily used for in clinical trials? Phenobarbital is primarily studied for treating seizures, especially in newborns (neonatal seizures). It's also investigated for use in alcohol withdrawal syndrome and as a potential preventive treatment for brain injuries in premature infants.
  • How effective is phenobarbital for treating neonatal seizures? Clinical trials suggest that phenobarbital is effective for treating neonatal seizures. It's often used as a first-line therapy and has shown to be effective in preventing subsequent seizures when administered at higher doses (40 mg/kg) compared to lower doses (20 mg/kg).
  • Are there any side effects associated with phenobarbital use in infants? While phenobarbital is generally considered safe, some studies are investigating potential long-term effects on brain development. Side effects can include sedation and respiratory depression, which is why careful monitoring is required during treatment.
  • How does phenobarbital compare to other medications for treating seizures? Some trials compare phenobarbital to other medications like lorazepam (Ativan) for treating seizures. The effectiveness can vary depending on the specific condition and patient. For neonatal seizures, phenobarbital is often considered a standard first-line treatment.
  • Is phenobarbital being studied for any conditions other than seizures? Yes, phenobarbital is being studied for other conditions. It's investigated as a treatment for alcohol withdrawal syndrome in adults and as a potential preventive measure for intracranial hemorrhage in premature infants when administered to pregnant women before delivery.

Ongoing Clinical Trials on Phenobarbital

  • Study on the Effects of Sirolimus and Drug Combination for Children Under 4 Months with Tuberous Sclerosis Complex

    Recruiting

    2 1 1 1
    Investigated drugs:
    Austria Germany

Glossary

  • Neonatal seizure: A seizure that occurs in a newborn baby, typically within the first 28 days of life. These seizures can be caused by various factors and may require prompt medical treatment.
  • Status epilepticus: A condition where a seizure lasts longer than 5 minutes or when multiple seizures occur without full recovery between them. It's a medical emergency requiring immediate treatment.
  • Electroencephalogram (EEG): A test that records the electrical activity of the brain. It's often used to diagnose seizures and monitor brain activity during treatment.
  • Intracranial hemorrhage: Bleeding inside the skull, which can be a serious complication in premature infants. Some studies investigate if phenobarbital can help prevent this condition.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion. This is important for understanding how medications like phenobarbital work in different patients.
  • Neonatal Abstinence Syndrome (NAS): A group of conditions that can occur when newborns withdraw from certain drugs they were exposed to before birth, often due to the mother using these substances during pregnancy.
  • Hypoxic-ischemic encephalopathy (HIE): A type of brain damage that occurs when an infant experiences a lack of oxygen and/or blood flow to the brain around the time of birth.

References

  1. https://clinicaltrials.gov/study/NCT03670160
  2. https://clinicaltrials.gov/study/NCT03602118
  3. https://clinicaltrials.gov/study/NCT05291455
  4. https://clinicaltrials.gov/study/NCT03650270
  5. https://clinicaltrials.gov/study/NCT04156464
  6. https://clinicaltrials.gov/study/NCT01089504
  7. https://clinicaltrials.gov/study/NCT01224457